Freestone Grove Partners LP Balchem Corp Transaction History
Freestone Grove Partners LP
- $13.4 Trillion
- Q3 2025
A detailed history of Freestone Grove Partners LP transactions in Balchem Corp stock. As of the latest transaction made, Freestone Grove Partners LP holds 3,320 shares of BCPC stock, worth $520,410. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,320
Previous 3,320
-0.0%
Holding current value
$520,410
Previous $529 Million
5.74%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BCPC
# of Institutions
439Shares Held
28.8MCall Options Held
70.4KPut Options Held
3.7K-
Black Rock Inc. New York, NY4.9MShares$769 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.89MShares$610 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC1.27MShares$200 Million3.07% of portfolio
-
State Street Corp Boston, MA1.2MShares$188 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.08MShares$169 Million0.91% of portfolio
About BALCHEM CORP
- Ticker BCPC
- Exchange NASDAQ
- Sector Basic Materials
- Industry Specialty Chemicals
- Shares Outstandng 32,120,600
- Market Cap $5.03B
- Description
- Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal N...